On the dose dependency of Cyclosporin a absorption and disposition in healthy volunteers
Tóm tắt
Từ khóa
Tài liệu tham khảo
R. J. Ptachcinski, R. Venkataramanan, and G. J. Burckart. The clinical pharmacokinetics of cyclosporine.Clin. Pharmacokin. 11:107–132 (1986).
R. J. Ptachcinski, R. Venkataramanan, G. J. Burckart, J. T. Rosenthal, R. J. Taylor, and T. R. Hakala. Dose-dependent absorption of cyclosporineDrug Intell. Clin. Pharm. 19:450 (1985).
B. D. Kahan. Individualization of cyclosporine therapy using pharmacokinetic and pharmacodynamic parameters. Transplantation40:457–476 (1985).
J. Grevel, E. Nüesch, E. Abisch, and K. Kutz. Pharmacokinetics of oral cyclosporin A in healthy subjects.Eur. J. Clin. Pharmacol. 31:211–216 (1986).
C. R. Abolin, H. F. Schran, D. W. Bitz, and S. Solar-Yohay.A Study of the Dose-Bioavailbility Relationship of Sandimmune Oral Solution in Normal Volunteers (Study No. 50), Sandoz Inc., East-Hanover, 1982.
D. Du Bois and E. F. Du Bois. A formula to estimate the approximate surface area if height and weight be known.Arch. Intern. Med. 17:863 (1916).
H. T. Smith and W. T. Robinson. Semi-automated liquid chromatographic method for the determination of cyclosporine in plasma and blood using column switching.J. Chromatog. 305:353–362 (1984).
R. J. Ptachcinski, R. Venkataramanan, G. J. Burckart, J. Gray, D. H. Van Thiel, A. Sanghvi, and J. T. Rosenthal. Cyclosporine kinetics in normal volunteers.J. Clin. Pharmacol. 27:243–248 (1987).
J. P. Reymond. In vitro in vivo Modelle zur Absorption von Cyclosporin A. Ph.D. dissertation, University of Basel, 1986.
L. B. Sheiner. ELSFIT, a program for the extended least squares fit to individual pharmacokinetic data. A technical report of the Division of Clinical Pharmacology, University of California, 1980.
D. Perrier and M. Mayersohn. Noncompartmental determination of the steady-state volume of distribution for any mode of administration.J. Pharm. Sci. 71:372–373 (1982).
P. R. Gwilt, M. C. Pankaskie, J. E. Thornburg, R. Zustiak, and D. R. Shoenthal. Pharmacokinetics of methylprylon following a single oral dose.J. Pharm. Sci. 74:1001–1003 (1985).
RS/1Version 12.00. BBN Research Systems, Cambridge, MA, 1984.
E. M. Landaw and J. J. Distefano III. Multiexponential, multicompartmental, and noncompartmental modeling II. Data analysis and statistical considerations.Am. J. Physiol. 246:R665-R677 (1984).
L. J. Lesko, J. Minor, D. Yocum, T. Emm, and J. H. Klippel. Pharmacokinetics of cyclosporine in patients with rheumatoid arthiritis.Clin. Pharmacol. Ther. 39:207 (1986).
S. Øie, T. W. Guentert, and T. N. Tozer. Effect of saturable binding on the pharmacokinetics of drugs: a simulation.J. Pharm. Pharmacol. 32:471–477 (1980).
K. Nussbaumer. Biopharmazeutische Untersuchungen mit Cyclosporin A: Bioanalytik und Pharmakokinetik. Ph.D. dissertation, University of Basel, Switzerland, 1984.
M. Rowland and T. Tozer.Clinical Pharmacokinetics, Lea and Febiger, Philadelphia, 1980, p. 45.
T. Beveridge. Pharmacokinetics and metabolism of Cyclosporin A. In D. J. G. White (ed.),Cyclosporin A, Elsevier Biomedical Press, Amsterdam, 1982, pp. 35–44.
R. J. Ptachcinski, R. Venkataraman, G. J. Burckart, S. Yang, and T. E. Starzl. Extraction ratio of cyclosporine in a liver transplant patient with organ rejection.J. Pharm. Sci. 74:901–902 (1985).
W. M. Awni and R. J. Sawchuk. The pharmacokinetics of cyclosporine. I. single dose and constant rate infusion studies in the rabbit.Drug Metab. Dispos. 13:127–132 (1985).
W. M. Awni and R. J. Sawchuck. The pharmacokinetics of cyclosporine. II. blood plasma distribution and binding studies.Drug Metab. Dispos. 13:133–138 (1985).
K. Nooter, F. Schultz, and P. Sonneveld. Evidence for a possible dose-dependent pharmacokinetic of cyclosporin A in the rat.Res. Commun. Chem. Pathol. Pharmacol. 43:407–415 (1984).
S. K. Gupta, B. Legg, L. R. Solomon, R. W. G. Johnson, and M. Rowland: Pharmacokinetics of cyclosporin: influence of rate of constant intravenous infusion in renal transplant patients.Br. J. Clin. Pharmacol. 24:519–526 (1987).
C. T. Ueda, M. Lemaire, G. Gsell, P. Misslin, and K. Nussbaumer. Apparent dose-dependent oral absorption of cyclosporin A in rats.Biopharm. Drug Dispos. 5:141–151 (1984).
P. J. McNamara, W. A. Colburn, and M. Gibaldi. Absorption kinetics of hydroflumethiazide.J. Clin. Pharmacol. 18:190–193 (1978).
P. G. Welling, L. L. Lyons, B. S. R. Elliott, and G. L. Amidon. Pharmacokinetics of alcohol following single low doses to fasted and non fasted subjects.J. Clin. Pharmacol. 17:199–206 (1977).
L. R. Whitfield, P. N. Kaul, and M. L. Clark. Chloropromazine metabolism. IX pharmacokinetics of chloropromazine following oral administration in man.J. Pharmacokin. Biopharm. 6:187–196 (1978).
R. M. J. Ings, J. R. Lawrence, A. McDonald, J. McEwan, A. W. Pidgen, and J. D. Robinson. Glibenclamide pharmacokinetics in healthy volunteers: Evidence for zero-order drug absorption.Proc. Br. Pharmacol. Soc.:264p–265p (1981).
T. W. Guentert, N. H. G. Holford, P. E. Coates, R. A. Upton, and S. Riegelman. Quinidine pharmacokinetics in man: choice of a disposition model and absolute bioavailability studies.J. Pharmacokin. Biopharm. 7:315–330 (1979).
M. Thibonnier, N. H. G. Holford, R. A. Upton, C. D. Blume, and R. L. Williams. Pharmacokinetic-pharmacodynamic analysis of unbound disopyramide directly measured in serial plasma samples in man.J. Pharmacokin. Biopharm. 12:559–573 (1984).
E. Redalieu, K. K. H. Chan, V. Tipnis, S. B. Zak, T. G. Gilleran, W. E. Wagner Jr., and A. R. LeSher. Kinetics of hydrochorothiazide absorption in humans.J. Pharm. Sci. 74:765–767 (1985).
J. R. Malagelada, J. S. Robertson, M. L. Brown, M. Remington, J. A. Duenes, G. M. Thomforde, and P. W. Carryer. Intestinal transit of solid and liquid components of a meal in health.Gastroenterology 87:1255–1263 (1984).
R. Wassef, Z. Cohen, S. Nordgren, and B. Langer. Cyclosporine absorption in intestinal transplantation.Transplantation 39:496–499 (1985).
R. Venkataramanan, T. E. Starzl, S. Yang, G. J. Burckart, R. J. Ptachcinski, B. W. Shaw, S. Iwatsuki, D. H. VanThiel, A. Sanghvi, and H. Seltman. Biliary excretion of cyclosporine in liver transplant patients.Transplant. Proc. 17(1):286–289 (1985).
J. Spenard, G. Sirois, and M. A. Gagnon. The second peak in the serum levels curve after oral administrtion of a slow-release quinidine dosage form: effect of food.Br. J. Clin. Pharmacol. 13:752–754 (1982).
P. G. Welling. Influence of food and diet on gastrointestinal drug absorption: a review.J. Pharmacokin. Biopharm. 5:291–334 (1977).
P. A. Keown, C. R. Stiller, M. Stawecki, J. McMichael, and W. Howson. Pharmacokinetics and interactions of ciclosporin In R. Schindler (ed.),Ciclosporin in Autoimmune Diseases, Springer Verlag, Berlin, 1985, pp. 39–42.
A. J. Wood and M. Lemaire. Pharmacologic aspects of cyclosporine therapy: Pharmacokinetics.Transplant. Proc. 17(4, Suppl 1):27–32 (1985).